1. Home
  2. FMNB vs ANNX Comparison

FMNB vs ANNX Comparison

Compare FMNB & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMNB
  • ANNX
  • Stock Information
  • Founded
  • FMNB 1887
  • ANNX 2011
  • Country
  • FMNB United States
  • ANNX United States
  • Employees
  • FMNB N/A
  • ANNX N/A
  • Industry
  • FMNB Major Banks
  • ANNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FMNB Finance
  • ANNX Health Care
  • Exchange
  • FMNB Nasdaq
  • ANNX Nasdaq
  • Market Cap
  • FMNB 598.6M
  • ANNX 668.8M
  • IPO Year
  • FMNB N/A
  • ANNX 2020
  • Fundamental
  • Price
  • FMNB $15.44
  • ANNX $5.17
  • Analyst Decision
  • FMNB Hold
  • ANNX Strong Buy
  • Analyst Count
  • FMNB 4
  • ANNX 7
  • Target Price
  • FMNB $15.25
  • ANNX $15.80
  • AVG Volume (30 Days)
  • FMNB 87.9K
  • ANNX 1.4M
  • Earning Date
  • FMNB 10-23-2024
  • ANNX 11-14-2024
  • Dividend Yield
  • FMNB 4.40%
  • ANNX N/A
  • EPS Growth
  • FMNB N/A
  • ANNX N/A
  • EPS
  • FMNB 1.23
  • ANNX N/A
  • Revenue
  • FMNB $162,960,000.00
  • ANNX N/A
  • Revenue This Year
  • FMNB N/A
  • ANNX N/A
  • Revenue Next Year
  • FMNB $5.71
  • ANNX N/A
  • P/E Ratio
  • FMNB $12.32
  • ANNX N/A
  • Revenue Growth
  • FMNB N/A
  • ANNX N/A
  • 52 Week Low
  • FMNB $11.55
  • ANNX $2.27
  • 52 Week High
  • FMNB $16.32
  • ANNX $8.40
  • Technical
  • Relative Strength Index (RSI)
  • FMNB 57.08
  • ANNX 20.68
  • Support Level
  • FMNB $14.87
  • ANNX $5.05
  • Resistance Level
  • FMNB $15.52
  • ANNX $7.63
  • Average True Range (ATR)
  • FMNB 0.44
  • ANNX 0.39
  • MACD
  • FMNB 0.03
  • ANNX -0.25
  • Stochastic Oscillator
  • FMNB 73.42
  • ANNX 4.84

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: